| 2020 |
Dongare-Bhor S, Lohiya N, Maheshwari A, Ekbote V, Chiplonkar S, Padidela R, Mughal Z, Khadilkar V, Khadilkar A. Muscle and bone parameters in underprivileged Indian children and adolescents with T1DM. Bone. January 2020;130:115074. |
3 |
2 |
| 2021 |
Shah N, Khadilkar A, Ekbote V, Mughal Z, Gondhalekar K, Khadilkar S, Ramanan V, Khadilkar V, Padidela R. DXA and pQCT derived parameters in indian children with beta thalassemia major: a case controlled study. Bone. February 2021;143:115730. |
0 |
0 |
| 2021 |
Ekbote V, Padidela R, Khadilkar V, Ramanan V, Maheshwari A, Mughal Z, Kariki EP, Crabtree N, Khadilkar A. Increased prevalence of fractures in inadequately transfused and chelated Indian children and young adults with beta thalassemia major. Bone. February 2021;143:115649. |
0 |
0 |
| 2021 |
Uday S, Shaw NJ, Mughal MZ, Randell T, Högler W, Santos R, Padidela R. Monitoring response to conventional treatment in children with XLH: value of ALP and rickets severity score (RSS) in a real world setting. Bone. October 2021;151:116025. |
0 |
0 |
| 2021 |
Padidela R, Whyte MP, Glorieux FH, Munns CF, Ward LM, Nilsson O, Portale AA, Simmons JH, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Williams A, Nixon A, Sun W, Chen A, Skrinar A, Imel EA. Patient-reported outcomes from a randomized, active-controlled, open-label, phase 3 trial of burosumab versus conventional therapy in children with x-linked hypophosphatemia. Calcif Tiss Int. May 2021;108(5):622-633. |
0 |
0 |